4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001655016-26-000002
Director acquired 339 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fox Jonathan C · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-01 | Grant or award : show line 1 in the form | +339 | 24,514 | D |
Loading xslF345X06/primarydocument.xml…